Thymic Carcinoma: A Cohort Study of Patients from the European Society of Thoracic Surgeons Database

Kód výsledku v IS VaVaI

<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00216208%3A11110%2F14%3A10286748" target="_blank" >RIV/00216208:11110/14:10286748 - isvavai.cz</a>

Nalezeny alternativní kódy

RIV/00064203:_____/14:10286748

Výsledek na webu

<a href="http://dx.doi.org/10.1097/JTO.0000000000000128" target="_blank" >http://dx.doi.org/10.1097/JTO.0000000000000128</a>

DOI - Digital Object Identifier

<a href="http://dx.doi.org/10.1097/JTO.0000000000000128" target="_blank" >10.1097/JTO.0000000000000128</a>

Jazyk výsledku

angličtina

Název v původním jazyce

Thymic Carcinoma: A Cohort Study of Patients from the European Society of Thoracic Surgeons Database

Popis výsledku v původním jazyce

Introduction: Thymic carcinoma is a rare and aggressive thymic neoplasm. The European Society of Thoracic Surgeons developed a retrospective database collecting patients undergoing resection for thymic tumors from 1990 to 2010. Methods: Of 2265 patientswith thymic tumors, there were 229 thymic carcinomas. Clinicopathological characteristics were analyzed including age, associated paraneoplastic diseases, stage (Masaoka-Koga), World Health Organization histologic subtypes, type of resection (total/subtotal/biopsy/no resection), tumor size, pre/postoperative treatments, and recurrence. Outcome measures included overall survival (OS), freedom from recurrence, and cumulative incidence of recurrence. Results: A complete resection was achieved in 140 patients (69%). Recurrence occurred in 54 patients (28%). Five- and 10-year OS rates were 0.61 and 0.37. Five- and 10-year freedom from recurrence rates were 0.60 and 0.43. Cumulative incidence of recurrence was 0.21 (3 yr), 0.27 (5 yr), and 0.

Název v anglickém jazyce

Thymic Carcinoma: A Cohort Study of Patients from the European Society of Thoracic Surgeons Database

Popis výsledku anglicky

Introduction: Thymic carcinoma is a rare and aggressive thymic neoplasm. The European Society of Thoracic Surgeons developed a retrospective database collecting patients undergoing resection for thymic tumors from 1990 to 2010. Methods: Of 2265 patientswith thymic tumors, there were 229 thymic carcinomas. Clinicopathological characteristics were analyzed including age, associated paraneoplastic diseases, stage (Masaoka-Koga), World Health Organization histologic subtypes, type of resection (total/subtotal/biopsy/no resection), tumor size, pre/postoperative treatments, and recurrence. Outcome measures included overall survival (OS), freedom from recurrence, and cumulative incidence of recurrence. Results: A complete resection was achieved in 140 patients (69%). Recurrence occurred in 54 patients (28%). Five- and 10-year OS rates were 0.61 and 0.37. Five- and 10-year freedom from recurrence rates were 0.60 and 0.43. Cumulative incidence of recurrence was 0.21 (3 yr), 0.27 (5 yr), and 0.

Druh

J_x - Nezařazeno - Článek v odborném periodiku (Jimp, Jsc a Jost)

CEP obor

FD - Onkologie a hematologie

OECD FORD obor

—

Projekt

—

Návaznosti

N - Vyzkumna aktivita podporovana z neverejnych zdroju

Rok uplatnění

2014

Kód důvěrnosti údajů

S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Název periodika

Journal of Thoracic Oncology

ISSN

1556-0864

e-ISSN

—

Svazek periodika

9

Číslo periodika v rámci svazku

4

Stát vydavatele periodika

US - Spojené státy americké

Počet stran výsledku

8

Strana od-do

541-548

Kód UT WoS článku

000333145300021

EID výsledku v databázi Scopus

—